StockNews.com began coverage on shares of Athersys (NASDAQ:ATHX – Free Report) in a research note published on Tuesday. The brokerage issued a hold rating on the biopharmaceutical company’s stock.
Athersys Stock Performance
NASDAQ ATHX opened at $0.00 on Tuesday. Athersys has a 52 week low of $0.01 and a 52 week high of $1.99. The company has a market capitalization of $166,641.30, a price-to-earnings ratio of 0.00 and a beta of -0.90.
Athersys Company Profile
Recommended Stories
- Five stocks we like better than Athersys
- What Are Dividend Champions? How to Invest in the Champions
- Top 3 Beverage Stocks: Summer Earnings Reveal Key Trends
- What is a buyback in stocks? A comprehensive guide for investors
- This Financial Stock’s Earnings Signal a Buying Opportunity
- What is the Dogs of the Dow Strategy? Overview and Examples
- Social Platform Stock Hits New Highs: Is More Growth Ahead?
Receive News & Ratings for Athersys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Athersys and related companies with MarketBeat.com's FREE daily email newsletter.